1. Home
  2. / Economy
  3. / Anvisa reveals flaws in supplements from IDNLABS and suspends 11 batches that include creatine, BCAA, beta-alanine, and multivitamins; the measure affects products with quality, composition, and labeling issues, while consumers are advised to check the printed codes on the packaging.
Reading time 3 min of reading Comments 0 comments

Anvisa reveals flaws in supplements from IDNLABS and suspends 11 batches that include creatine, BCAA, beta-alanine, and multivitamins; the measure affects products with quality, composition, and labeling issues, while consumers are advised to check the printed codes on the packaging.

Written by Viviane Alves
Published on 20/06/2026 at 01:31
Updated on 20/06/2026 at 01:32
Be the first to react!
React to this article

Decision published on June 19, 2026 halts sale, distribution, and use of products while the manufacturer conducts voluntary recall

A health decision involving dietary supplements raised an alert among Brazilian consumers this Friday, June 19, 2026.

The National Health Surveillance Agency (Anvisa) suspended the commercialization, distribution, and use of 11 batches of IDNLABS supplements.

The determination affects products of creatine, BCAA, beta-alanine, multivitamins, and multiminerals.

The manufacturer announced the start of the voluntary recall of the batches included in the decision.

The measure was formalized by Resolution-RE nº 2.149/2026, published in the Official Gazette of the Union.

Person holds smartphone with Anvisa identification in article about suspended batches of creatine, BCAA, beta-alanine, and multivitamins.
Illustrative image shows a person holding a cellphone with the identification of Anvisa, the agency responsible for suspending the batches of IDNLABS supplements.

Inspection found flaws in the supplements

Quality tests identified quantities of ingredients below the values stated on the packaging, according to data released by Anvisa.

The inspection found consumption recommendations exceeding the limits authorized by health regulations.

Problems in the designation of the supplements and in the presentation of mandatory information were also recorded.

Some labels presented unauthorized claims for the dietary supplements category.

The consumption recommendation for beta-alanine was not in accordance with the conditions permitted by legislation.

The irregularities led to the cancellation of the sanitary notifications of the products.

Scoop with powdered creatine above open container, in illustrative image about the suspension of supplement batches by Anvisa.
Illustrative image shows a scoop of powdered creatine over the open packaging, a product related to the batches of supplements suspended by Anvisa.

Creatine had three batches suspended

Three batches of creatine powder dietary supplement were included in Anvisa’s decision:

  • 0147.05.2025
  • 0148.05.2025
  • 0285.05.2025

Products with these identifications cannot be marketed, distributed, or used while the suspension remains in effect.

BCAA entered the list of affected products

The determination also reached three batches of BCAA 2-1-1 in tablets:

  • 003.01.2025
  • 004.01.2025
  • 044.01.2025

The sale and use of these batches remain halted until a new decision by the health authority.

https://en.clickpetroleoegas.com.br/anvisa-barra-lote-de-antibiotico-apos-descoberta-inesperada-em-frasco-lacrado-e-ainda-suspende-clindamicina-com-impurezas-e-soro-fisiologico-usado-em-aplicacao-intravenosa-vacs75/#google_vignette

Beta-alanine showed irregular recommendation

Three batches of beta-alanine powder were also included in the resolution:

  • 0267.08.2025
  • 0149.05.2025
  • 079.02.2025

Anvisa reported that the product’s usage recommendation was outside the authorized conditions.

Multivitamins were also suspended

Two batches of multivitamins and multiminerals in coated tablets were included in the measure:

  • 005.01.2026
  • 0211.07.2025

The inspection identified the absence of mandatory warnings and difficulties in viewing the information on the labels.

These issues contributed to the cancellation of the supplements’ notifications.

What should the consumer do?

Consumers who have supplements from IDNLABS should check the batch number printed on the packaging.

Use should be discontinued when the identification matches any of the suspended batches.

The consumer should contact the manufacturer to receive guidance on the recall.

The prohibition will remain valid until a new decision by Anvisa.

IDNLABS had not yet presented a position

The report sought IDNLABS to request clarifications about the suspended batches and the measures taken.

The company had not yet presented a position by the time this article was closed.

The information was disclosed by the National Health Surveillance Agency and the Official Gazette of the Union.

Do you usually check the batch, composition, and warnings before consuming creatine or other supplements? Leave your opinion!

Sign up
Notify of
guest
0 Comments
most recent
older Most voted
Viviane Alves

Writer specializing in the production of strategic content covering macro and microeconomics, geopolitics, the energy market, the automotive sector, and global trade.

Share in apps
Download app
0
I'd love to hear your opinion, please comment.x